收费全文 | 2805682篇 |
免费 | 185863篇 |
国内免费 | 4159篇 |
耳鼻咽喉 | 38386篇 |
儿科学 | 90676篇 |
妇产科学 | 74149篇 |
基础医学 | 412600篇 |
口腔科学 | 77345篇 |
临床医学 | 252115篇 |
内科学 | 538946篇 |
皮肤病学 | 61937篇 |
神经病学 | 217658篇 |
特种医学 | 104009篇 |
外国民族医学 | 552篇 |
外科学 | 418186篇 |
综合类 | 58096篇 |
现状与发展 | 12篇 |
一般理论 | 963篇 |
预防医学 | 215950篇 |
眼科学 | 65408篇 |
药学 | 208605篇 |
63篇 | |
中国医学 | 6237篇 |
肿瘤学 | 153811篇 |
2021年 | 22744篇 |
2019年 | 23554篇 |
2018年 | 31577篇 |
2017年 | 23847篇 |
2016年 | 26720篇 |
2015年 | 29987篇 |
2014年 | 42206篇 |
2013年 | 63362篇 |
2012年 | 86728篇 |
2011年 | 91855篇 |
2010年 | 54671篇 |
2009年 | 51679篇 |
2008年 | 86331篇 |
2007年 | 92018篇 |
2006年 | 93093篇 |
2005年 | 89774篇 |
2004年 | 86204篇 |
2003年 | 82716篇 |
2002年 | 80346篇 |
2001年 | 129466篇 |
2000年 | 132654篇 |
1999年 | 111240篇 |
1998年 | 31854篇 |
1997年 | 27821篇 |
1996年 | 28214篇 |
1995年 | 26732篇 |
1994年 | 24598篇 |
1993年 | 23132篇 |
1992年 | 85983篇 |
1991年 | 83927篇 |
1990年 | 81727篇 |
1989年 | 79107篇 |
1988年 | 72750篇 |
1987年 | 71252篇 |
1986年 | 66886篇 |
1985年 | 63824篇 |
1984年 | 47423篇 |
1983年 | 40282篇 |
1982年 | 23657篇 |
1979年 | 43593篇 |
1978年 | 30962篇 |
1977年 | 25854篇 |
1976年 | 24759篇 |
1975年 | 26637篇 |
1974年 | 31885篇 |
1973年 | 30433篇 |
1972年 | 28520篇 |
1971年 | 26936篇 |
1970年 | 25112篇 |
1969年 | 23740篇 |
Introduction
Malignant pleural mesothelioma (MPM) is an uncommon cancer with a poor prognosis and heterogeneous survival. Surgery for MPM is offered in some specialist centers to highly selected patients. A previously described classification and regression tree (CART) model stratified survival in unselected MPM patients using routinely collected clinical data. This study aimed to examine the performance of this CART model on a highly selected surgical population.Methods
Data were collected from subjects undergoing cytoreductive surgery for MPM from specialist centers in Hyõgo, Japan, and Sydney, Australia, between 1991 and 2016. The CART model was applied using the combination of clinical variables to stratify subjects into risk groups (1 through 4); survival characteristics were then compared.Results
Two hundred eighty-nine cases were included (205 from Australia, 84 from Japan). Overall median survival was 34.6 (interquartile range: 17.5–56.1) months; median age was 63.0 (interquartile range: 57.0–67.8) years, and 83.0% (n = 240) were male. There were no clinically meaningful differences between the two cohorts. Survival across the four risk groups was significantly different (p < 0.0001); the model stratified survival well with a Harrell's concordance statistic of 0.62 (95% confidence interval: 0.57–0.66) at 36 months. The group with the longest survival (median, 82.5 months) had: no weight loss, hemoglobin > 153 g/L and serum albumin > 43 g/L at time of referral to the surgical center.Conclusions
Using routinely available clinical variables, the CART model was able to stratify surgical patients into risk groups with statistically different survival characteristics with fair to good performance. Presence of weight loss, anemia, and low albumin should confer caution when considering surgical therapy for MPM. 相似文献Cellular arachidonic acid (AA), an unsaturated fatty acid found ubiquitously in plasma membranes, is metabolized to different prostanoids, such as prostacyclin (PGI2) and prostaglandin E2 (PGE2), by the three-step reactions coupling the upstream cyclooxygenase (COX) isoforms (COX-1 and COX-2) with the corresponding individual downstream synthases. While the vascular actions of these prostanoids are well-characterized, their specific roles in the hippocampus, a major brain area for memory, are poorly understood. The major obstacle for its understanding in the brain was to mimic the biosynthesis of each prostanoid. To solve the problem, we utilized Single-Chain Hybrid Enzyme Complexes (SCHECs), which could successfully control cellular AA metabolites to the desired PGI2 or PGE2. Our in vitro studies suggested that neurons with higher PGI2 content and lower PGE2 content exhibited survival protection and resistance to Amyloid-β-induced neurotoxicity. Further extending to an in vivo model, the hybrid of PGI2-producing transgenic mice and Alzheimer’s disease (AD) mice showed restored long-term memory. These findings suggested that the vascular prostanoids, PGI2 and PGE2, exerted significant regulatory influences on neuronal protection (by PGI2), or damage (by PGE2) in the hippocampus, and raised a concern that the wide uses of aspirin in cardiovascular diseases may exert negative impacts on neurodegenerative protection.
相似文献